3'', 4''-Dideoxy-Kanamycin B Active Against Kanamycin-Resistant Escherichia Coli and Pseudomonas Aeruginosa

Journal of Antibiotics - United Kingdom
doi 10.7164/antibiotics.24.485
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Antibiotics Research Association

Related search

Purification and Properties of Kanamycin-Phosphorylating Enzyme From Pseudomonas Aeruginosa

Journal of Antibiotics
Drug DiscoveryPharmacology
1969English

In Vitro Comparison of Kanamycin, Kanendomycin, Gentamicin, Amikacin, Sisomicin, and Dibekacin Against 200 Strains of Pseudomonas Aeruginosa

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1978English

Two Enzymes Which Phosphorylate Neomycin and Kanamycin in Escherichia Coli Strains Carrying R Factors

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1973English

Syntheses and Properties of the 6"-Deoxy or 4",6"-Dideoxy Derivatives of the Kanamycin Antibiotics.

Journal of Antibiotics
Drug DiscoveryPharmacology
1980English

Syntheses of 1-N-(2-Aminoethoxycarbonyl)kanamycin a and 1-N-(3-Aminopropoxycarbonyl)kanamycin A.

Journal of Antibiotics
Drug DiscoveryPharmacology
1981English

Syntheses of 6''-N-Methyl-Kanamygin and 3'', 4''-Dideoxy-6''-N-Methylkanamycin B Active Against Resistant Strains Having 6''-N-Acetylating Enzymes

Journal of Antibiotics
Drug DiscoveryPharmacology
1972English

In Vivo Activation by Polymyxin B of Phospholipase From Pseudomonas Aeruginosa and Escherichia Coli.

Journal of Antibiotics
Drug DiscoveryPharmacology
1976English

Synthesis of 4''-Deoxykanamycin and Its Resistance to Kanamycin

Journal of Antibiotics
Drug DiscoveryPharmacology
1974English

Synergy of Penicillin-Netilmicin Combinations Against Enterococci Including Strains Highly Resistant to Streptomycin or Kanamycin

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1977English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy